The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hope you're right chaps, really do.
Tempted to reach for my calculator, better not, the figures are unreal.
3P is non starter. We should get at least what Moony got ~7P. However more than 10P will be a good one.
Yes, 57m is quite the stack.
I think a buyout 5p+
3p+ on blue hat and product launch.
Hi gixer thankyou yet again for information.I bought the 2 million at .95 the other day to add to 55 million already held. unfortunately dropped a bit.my view is a buyout and although I think it will be 3p which is an ok reward but considering a lot of us have been here circa 10 years I would hope for more.any views anybody??
Thanks for the work you put in Gixer. It does sound like, after over ten years here, might be at the start of something progressive.
Starting to feel seasick watching the SP everyday.
Not sure what the CCP (Chinese comunist party?) has to do about anything.
50p a day would be a complete guess as who knows what By-Health will sell any FF products for or what advertising budget they will have but if some of there other products are anything to go by, well that could be a reasonable amount.
There are now over 350 million middle class consumers in Mainland China representing the largest dietary supplements market in the world.
This years, the market of vitamin and dietary supplements in China is expected to reach CNY 149 billion (US$22.3 billion), with a CAGR of 6.4% in the 2015-2020 period.
Actually, accordng to JD.com, the sale of vitamin and dietary supplement has been multiplied by 5 since the beginning of the Covid-19 pandemic.
https://seoagencychina.com/vitamins-and-dietary-supplements-market-in-china/#:~:text=There%20are%20now%20over%20350,in%20the%202015%2D2020%20period.
Ever hopeful you’re wrong on a couple of points there , you forget that China is still a communist state , the state could purchase on a large scale and of course at a discount to what we pay , also this statement from the results shows there’s an appetite for proven health products , “ China is now the world's second-largest pharmaceuticals market, measured by how much patients and the state spend on drugs (source: health-care information company IQVIA). The Company believes that Fruitflow has the potential to play an important role in the Chinese cardiovascular health market.” Lastly the new distributor for CBEC have access to e commerce sites and it will be their responsibility to advertise and promote (if they want o sell anything ). We are all frustrated at the moment , it seems to me that the most important thing is for By health to get Blue cap , at that stage it will be in their interest to promote the hell out of the new products , imho
No the CCP wont imo . 230 mill with heart disease how many can afford FF at 50p a day ( it will not get cheaper as it is about making money). There are 300 mill affluent people in China how many of them need FF? many would benefit as we know but to get the message to them there needs to be a massive advertising campaign which would cost $10's of millions as it would need to be sustained. PXS is the same long odds gamble as it was 10 years ago.
There are many other things they can spend advertising on and there are many other products being developed that might be cheaper and more effective. I hopefully wait since I am under water but some reality should be sprinkled on this Ian Ford benevolent fund.
Nearly 3 months of moving sideways! almost a record length of time , no one selling or buying much at the moment , only news it seems will move this now, let’s hope the next news is not the finals in Sept . With lots going on behind the scenes we can only hope for good news soon .
Also good to know trials are up and running again !
"Funding
This work was supported by grants from By-Health Co., Ltd. (Zhuhai, Guangdong, China), and the National Natural Science Foundation of China (grant no. 91649110)."
"Conclusion: Fruitflow® suppressed platelet aggregation and decreased TXB2, 6-keto-PGF1a, and PF4 levels in elderly participants. These findings indicate that FF might reduce the risk of thrombosis in cardiovascular diseases.
Trial registration code: ChiCTR2000034647 at www.clinicaltrials.gov."
http://www.chictr.org.cn/historyversionpuben.aspx?regno=ChiCTR2000034647
Another great find , carried out in Beijing , let’s hope the Chinese government take note and want to help the 230 m people with cardiovascular disease in China .
Version 2
Posted 01 Feb, 2021
CURRENT STATUS: UNDER REVIEW
Inhibitory effect of Fruitflow on platelet function: a randomized placebo-controlled trial in elderly subjects
https://www.researchsquare.com/article/rs-95541/v2
Same here, bought in at .79, £1000 worth. Didn't show up on this site ?
There are far fewer trades go through on Aquis (PXS.GB.PL) but you can check back a good few trades on here.
https://www.lse.co.uk/ShareTrades.asp?shareprice=PXS.GB.PL&share=Provexis-Plc
* "good idea!!"
No but that's a good idea ?? iv bought in 4 batches and not one shown as I bought it. It's very strange have no idea why they are doing it! Been here since the beginning but finally looks like it's time to make some money ??. Have a good day.
Interesting Mjburgess07,
Did you also check the Aquis Exchange to see is your trades were reported on there?
We normally get a few new products in this month. Let's hope it's a biggy
The small trades are just bigger trades broken down to cover them up. It's been happening here a while now as iv been slowly buying in hope! But not one off my trades has shown but if I add a few together you can see there mine ??
Not sure I ever gave a date and I wouldn't like to guess but would like to hope that it will be this year. From reports in links found it can take a long time for the regulatory process of blue cap (3 or 4? Years) but does appear to be getting quicker. If we knew when by-health had submitted their first submission we might have had a better idea of time scale.
No doubt there will be delays due to covid as well.
Thanks gix. Can you remind me when you thought the earliest date for blue hat may be. I seem to have March in mind? Thanks.
No.
Blocks of small trades all at the same time. Happens on other shares as well but no idea what or who is doing it.
Anyone know what that's all about?
... 25.83% now. That's more like it.